Njoga Emmanuel O, Mshelbwala Philip P, Abah Kenneth O, Awoyomi Olajoju J, Wangdi Kinley, Pewan Shedrach B, Oyeleye Felix A, Galadima Haruna B, Alhassan Salisu A, Okoli Chinwe E, Kwaja Elisha Z, Onwumere-Idolor Onyinye S, Atadiose Everest O, Awoyomi Priscilla O, Ibrahim Musawa A, Lawan Kabiru M, Zailani Shehu A, Salihu Mohammed D, Rupprecht Charles E
Department of Veterinary Public Health and Preventive Medicine, Faculty of Veterinary Medicine, University of Nigeria, Nsukka 410001, Nigeria.
School of Veterinary Science, University of Queensland, Gatton 4343, Australia.
Vaccines (Basel). 2022 Apr 15;10(4):626. doi: 10.3390/vaccines10040626.
The COVID-19 pandemic has resulted in millions of human deaths, prompting the rapid development and regulatory approval of several vaccines. Although Nigeria implemented a COVID-19 vaccination program on 15 March 2021, low vaccine acceptance remains a major challenge. To provide insight on factors associated with COVID-19 vaccine hesitancy (VH), we conducted a national survey among healthcare workers, academics, and tertiary students, between 1 September 2021 and 31 December 2021. We fitted a logistic regression model to the data and examined factors associated with VH to support targeted health awareness campaigns to address public concerns and improve vaccination rates on par with global efforts. A total of 1525 respondents took part in the survey, composed of healthcare-workers (24.5%, 373/1525), academics (26.9%, 410/1525), and students (48.7%, 742/1525). Only 29% (446/1525) of the respondents were vaccinated at the time of this study. Of the 446 vaccinated respondents, 35.7% (159/446), 61.4% (274/446) and 2.9% (13/446) had one, two and three or more doses, respectively. Reasons for VH included: difficulty in the vaccination request/registration protocols (21.3%, 633/1079); bad feelings towards the vaccines due to negative social media reports/rumours (21.3%, 633/1079); personal ideology/religious beliefs against vaccination (16.7%, 495/1079); and poor confidence that preventive measures were enough to protect against COVID-19 (11%, 323/1079). Some health concerns that deterred unvaccinated respondents were: innate immunity issues (27.7%, 345/1079); allergic reaction concerns (24.6%, 307/1079); and blood clot problems in women (21.4%, 266/1079). In the multivariable model, location of respondents/geopolitical zones, level of education, testing for COVID-19, occupation/job description and religion were significantly associated with VH. Findings from this study underscore the need for targeted awareness creation to increase COVID-19 vaccination coverage in Nigeria and elsewhere. Besides professionals, similar studies are recommended in the general population to develop appropriate public health interventions to improve COVID-19 vaccine uptake.
新冠疫情已导致数百万人死亡,促使多种疫苗迅速研发并获得监管批准。尽管尼日利亚于2021年3月15日实施了新冠疫苗接种计划,但疫苗接受度低仍是一项重大挑战。为深入了解与新冠疫苗犹豫(VH)相关的因素,我们于2021年9月1日至2021年12月31日期间,在医护人员、学者和大学生中开展了一项全国性调查。我们对数据拟合了逻辑回归模型,并研究了与VH相关的因素,以支持有针对性的健康宣传活动,解决公众关切并提高疫苗接种率,与全球努力保持一致。共有1525名受访者参与了此次调查,其中包括医护人员(24.5%,373/1525)、学者(26.9%,410/1525)和学生(48.7%,742/1525)。在本研究开展时,只有29%(446/1525)的受访者接种了疫苗。在446名接种疫苗的受访者中,分别有35.7%(159/446)、61.4%(274/446)和2.9%(13/446)接种了一剂、两剂和三剂及以上疫苗。VH的原因包括:疫苗接种申请/登记流程困难(21.3%,633/1079);因社交媒体负面报道/谣言而对疫苗产生不良印象(21.3%,633/1079);个人意识形态/宗教信仰反对接种疫苗(16.7%,495/1079);以及对预防措施足以预防新冠病毒缺乏信心(11%,323/1079)。一些阻碍未接种疫苗受访者的健康担忧包括:先天免疫问题(27.7%,345/1079);过敏反应担忧(24.6%,307/1079);以及女性的血栓问题(21.4%,266/1079)。在多变量模型中,受访者的所在地/地缘政治区域、教育水平、新冠病毒检测、职业/工作描述和宗教与VH显著相关。本研究结果强调了开展有针对性的宣传以提高尼日利亚及其他地区新冠疫苗接种覆盖率的必要性。除了专业人员外,建议在普通人群中开展类似研究,以制定适当的公共卫生干预措施,提高新冠疫苗接种率。